Americans who fill prescriptions through Canadian and other international mail-order pharmacies have about three weeks before a federal customs rule reaches its compliance deadline on October 22, and a growing number of members of Congress are urging the Trump administration to reconsider it. The rule, issued by U.S. Customs and Border Protection (CBP), does not name any drug or ban prescriptions outright. But it could make routine personal shipments far harder and costlier to deliver, STAT reported.
For many households, this is a budget issue first. People who order insulin, inhalers, blood thinners, or cancer drugs from abroad usually do so because the same medicine costs much more at a U.S. pharmacy. If shipments stall, patients could face gaps in treatment or a sudden jump in monthly costs.
